https://www.pharma-marketing.com/esperion-to-acquire-corstasis-to-add-enbumyst-to-its-cv-portfolio/
Esperion to acquire Corstasis and add Enbumyst – Pharma-Marketing.com
Esperion has agreed to acquire Corstasis for $75m upfront plus milestones and royalties, adding FDA-approved Enbumyst (bumetanide nasal spray).
esperionacquireaddenbumystpharma